MedDataX Logo

Prescription Audit in OPD of NABH & JCI Approved Hospital in Capital Territory of India

NCT05729412 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-06-07

No results posted yet for this study

Summary

Aim of the study: The aim of the study is to evaluate the quality of the prescription provided to the outpatient.

Need of study:

For the promotion of the good clinical practice To improve the efficiency of the multidisciplinary team in the healthcare To utilize resources to provide better patient care To improve quality standards and quality of care For implication of professional practices To identify and eliminate deficient practice

Objectives:

1. To study the quality of good prescription
2. In minimization of prescription errors and medication errors
3. Also to comply with good clinical practice
4. Enhancement of patient safety
5. In the maintenance of rational prescribing
6. To study the quality of care provided by the hospital to the patient

Plan of study:

* To select the patient based on inclusion and exclusion criteria
* To collect the information from OP's prescription
* To identify prescribing errors and medication error
* To study the management of good prescription

Study Sites: Max Super Speciality Hospital, Saket, New Delhi (INDIA) Study Design: Observational cohort study Study Duration: 1 month (November 2022)

Conditions

  • Quality of Life

Interventions

OTHER

Mentioned

If prescription is properly filled for specific details than it is compliance

Sponsors & Collaborators

  • Kakatiya University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-01-01
Completion
2023-01-01

Countries

  • India

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05729412 on ClinicalTrials.gov